[Event Report] HGPI Dementia Policy Project Hosts Advisory Board Meeting for “Current Issues and Future Prospects for Idiopathic Normal Pressure Hydrocephalus (iNPH) Measures – Focusing on a Form of Dementia that Improves with Treatment” (June 10, 2022)
date : 6/29/2022
Tags: Dementia
On June 10, 2022, Health and Global Policy Institute (HGPI) hosted a meeting of the advisory board for an initiative titled, “Current Issues and Future Prospects for Idiopathic Normal Pressure Hydrocephalus (iNPH) Measures – Focusing on a Form of Dementia that Improves with Treatment.” This initiative is being undertaken as one of the Dementia Policy Team’s activities for FY2022.
Projections show that the number of people living with dementia in Japan will soon exceed 7 million, and hopes are high for treatments that relieve the symptoms of dementia and address its underlying causes for better living later in life. Many diseases that cause dementia are considered difficult to treat, but iNPH is a form of dementia that improves with treatment. It is estimated that iNPH affects around 370,000 people or about 5% of all people living with dementia. As has been pointed out in recent years, the actual number of cases likely exceeds estimates due to the fact that iNPH often occurs alongside Alzheimer’s disease, the most common cause of dementia. There are many potential benefits to delivering the appropriate treatments to people with iNPH. In addition to longer life expectancies, these include fall prevention and high returns in terms of health economics. As demonstrated by developments like the adoption of the “Research Survey on Structuring Healthcare for a Treatable Form of Dementia” as a Ministry of Health, Labour and Welfare Project for the Promotion of Well-Being for Elderly People, the importance of iNPH is also growing in terms of the policy.
However, scattered issues must be addressed before iNPH treatments can be delivered to improve dementia symptoms and elevate the quality of life for as many people as possible. First, dementia is diagnosed in various clinical settings such as medical centers for dementia or the clinics of family doctors. Despite the importance of early and accurate diagnosis, it is hard to say that awareness of iNPH is high among healthcare providers compared to the various other forms of dementia. Second, after receiving diagnoses from specialists in dementia such as psychiatrists or neurologists, iNPH requires collaboration across disciplines. For example, it must involve neurosurgeons, who implant catheters at sites with poor circulation of cerebrospinal fluid (CSF) or perform shunt procedures to continuously drain excess CSF to the abdomen and relieve brain pressure. Furthermore, there are clear regional disparities in treatment, so hopes are high for steps to expand and enhance treatment provision systems to achieve nationwide equity in care.
To address these diverse issues with an all-of-society response, this project will identify necessary measures and compile policy recommendations based on multi-stakeholder discussions with industry, Government, academia, and civil society with participation from related healthcare professionals, academia, representatives of the private sector, and people living with iNPH. Based on the discussion held at the preparatory meeting in March, this advisory board meeting was held with multi-stakeholders from industry, government, academia, and civil society and covered issues and potential methods for promoting iNPH measures with a focus on the healthcare provision system.
In light of COVID-19, this meeting was held remotely using an online conferencing system.
Advisory board members (Titles omitted; in alphabetical order)
- Chifumi Iseki (Lecturer, Department of Internal Medicine III, Faculty of Medicine, Yamagata University)
- Kazunari Ishii (Department Head, Diagnostic Radiology Division, Department of Radiology, Faculty of Medicine, Kindai University)
- Hiroaki Kazui (Professor, Department of Neuropsychiatry, Kochi Medical School)
- Madoka Nakajima (Associate Professor, Department of Neurosurgery, School of Medicine, Juntendo University)
- Tomoya Sato (Manager, Head of Hydrocephalus and Dementia Care Promotion, Integra Japan)
- Shigeki Yamada (Hospital Lecturer, Department of Neurosurgery, Shiga University of Medical Science)
- Manabu Yanagiishi (Central Group, Marketing Department, Sales, and Marketing Division, Nihon Medi-Physics Co., Ltd.)
Representative of the affected party
- T.S. (70s, male)
Observer
- Aki Nakanishi (Deputy Director, Chief of Research and Development, Division of Dementia Policy and Community-Based Long-Term Care Promotion, Health and Welfare Bureau for the Elderly, Ministry of Health, Labour and Welfare (MHLW); Technical Officer (Dementia), Division of the Heath for the Elderly, MHLW)
日本語
Top Research & Recommendations Posts
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Publication Report] Guidance on Patient and Public Involvement (PPI) in Health Policymaking: Necessary Initiatives and Good Examples from the Public and Government (March 31, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Research Report] Healthcare DX Project Research Report of Interviews ”Expectations for the Coming Era of Healthcare DX from People Living with Health Concerns” (June 10, 2024)
- [Policy Recommendations] Recommendation for the Basic Policy on Economic and Fiscal Management and Reform 2024 (June 11, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
Featured Posts
-
2024-06-21
[Event Report] HGPI Special Seminar – HGPI Celebrates its 20th Anniversary: Reflecting on HGPI’s Journey from the Past to the Future (January 16, 2024)
-
2024-06-25
[Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
-
2024-06-26
[Event Report] Global Expert Meeting “Innovation in Cancer Care in Developing Countries ~City Cancer Challenge Initiatives“ (June 20, 2024)
-
2024-06-26
[Registration Open] (Webinar) The 127th HGPI Seminar: Current Issues and Future Prospects in Establishing a Health System and Protecting Public Health Through Policy (July 18, 2024)
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)